Cart
sales@molnova.com
VB-82252
CAS No. 2170004-34-7
VB-82252( VB82252 )
Catalog No. M13463 CAS No. 2170004-34-7
VB-82252 is a highly potent, orally active inhibitor of C. difficile toxins TcdA and TcdB, potently inhibits UDP glucose hydrolysis activity of TcdB (IC50=32 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameVB-82252
-
NoteResearch use only, not for human use.
-
Brief DescriptionVB-82252 is a highly potent, orally active inhibitor of C. difficile toxins TcdA and TcdB, potently inhibits UDP glucose hydrolysis activity of TcdB (IC50=32 nM).
-
DescriptionVB-82252 is a highly potent, orally active inhibitor of C. difficile toxins TcdA and TcdB, potently inhibits UDP glucose hydrolysis activity of TcdB (IC50=32 nM); protects CHO-K1 cells against challenge with purified TcdA (IC50 = 5.0 uM) or TcdB (IC50=0.25 uM); prevents inflammation in murine intrarectal toxin challenge model, reduces weight loss and gut inflammation during acute disease in murine model of recurrent Clostridium difficile infection (CDI), demonstrates efficacy similar to that of vancomycin.
-
In Vitro——
-
In Vivo——
-
SynonymsVB82252
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorAntibacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2170004-34-7
-
Formula Weight614.406
-
Molecular FormulaC29H20Cl2F3N5O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name(R)-2-chloro-4-((8-chloro-2,5-dioxo-3-(pyridin-2-ylmethyl)-1,2,3,5-tetrahydro-4H-benzo[e][1,4]diazepin-4-yl)methyl)-N-(5-(trifluoromethyl)pyridin-2-yl)benzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Stroke IL, et al. Antimicrob Agents Chemother. 2018 Apr 26;62(5). pii: e00107-18.
molnova catalog
related products
-
HMPC
HMPC is a novel bacteriostatic agent that shows bacteriostatic activity against S. aureus (MIC=4?μg/ml) and rescues Caenorhabditis elegans from S. aureus infection.
-
Chlamydia pneumoniae...
Chlamydia pneumoniae-IN-1 (compound 55), a benzimidazole derivative, exhibits potent antibacterial activity, inhibiting 99% of C. pneumoniae growth at a concentration of 10 μM while maintaining 95% viability of host cells.
-
Midecamycin
Midecamycin an acetoxy-substituted macrolide antibiotic has effective on gram-positive and gram-negative bacteria acts by inhibiting bacterial protein synthesis.
